Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 20Brain Neoplasms 10Glioblastoma 5Glioma 4Neoplasms 3Uterine Cervical Neoplasms 2Urogenital Diseases 2Disease 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Prostate Adenocarcinoma 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Multiple Myeloma 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Follicular 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Breast Neoplasms 1

Interventions

fluciclovine F-18 2relatlimab 1pembrolizumab 1enfortumab vedotin 1darolutamide 1Watchful Waiting 1Transurethral Resection of Prostate 1Sunitinib 1Radiotherapy 1Radiation Dose Hypofractionation 1Pregnancy Tests 1Nivolumab 1Mitomycin 1Magnetic Resonance Spectroscopy 1Human Papillomavirus DNA Tests 1Gemcitabine 1Fluorouracil 1Colposcopy 1Cisplatin 1Biopsy 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urogenital Diseases × fluciclovine F-18 × Clear all
NCT03081884 2021-01-25

EDRN-FACBC

Emory University

Phase 2 Completed
61 enrolled 6 charts
Genitourinary

Urogenital Diseases, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT02830880 2020-01-07

FACBC Prostate Therapy Response

Emory University

Phase 2 Completed
7 enrolled 10 charts
Genitourinary

Urogenital Diseases, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡